Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05020678 |
Title | NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Nkarta Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Colorado Blood Cancer Institute | RECRUITING | Denver | Colorado | 80218 | United States | Details |
University of Chicago | WITHDRAWN | Chicago | Illinois | 60637 | United States | Details |
The Cleveland Clinic Foundation | RECRUITING | Cleveland | Ohio | 44195 | United States | Details |
Institute of Haematology, Royal Prince Alfred Hospital | RECRUITING | Camperdown | New South Wales | 2050 | Australia | Details |
St. Vincent's Hospital | RECRUITING | Sydney | New South Wales | 2010 | Australia | Details |
Royal Brisbane and Woman's Hospital | RECRUITING | Brisbane | Queensland | 4029 | Australia | Details |
Peter MacCallum Cancer Center | RECRUITING | Melbourne | Victoria | 3000 | Australia | Details |